Skip to product information
1 of 1

GeneBio Systems

PI 3 kinase p85 alpha Monoclonal Antibody

PI 3 kinase p85 alpha Monoclonal Antibody

SKU:E-AB-22164

Regular price £424.00 GBP
Regular price Sale price £424.00 GBP
Sale Sold out
Shipping calculated at checkout.

Size: 200μL

Storage: Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.

Shipping: The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended.

Exp date: 12 months

Category ID_II: Primary Antibodies

Category ID_III: Monoclonal Antibodies

Abbreviation: PI3 Kinase P85α

Target Synonym: GRB1;p85 alpha;p85;P85A;Phosphatidylinositol 3 kinase associated p 85 alpha;Phosphatidylinositol 3 kinase regulatory 1;Phosphatidylinositol 3 kinase;regulatory subunit;polypeptide 1 (p85 alpha);Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha;Phosphatidylinositol 3-kinase regulatory subunit alpha;Phosphoinositide 3 kinase;regulatory subunit 1 (alpha);PI3 kinase p85 subunit alpha;PI3-kinase regulatory subunit alpha;PI3-kinase subunit p85-alpha;PI3K;PI3K regulatory subunit alpha;Pik3r1;PtdIns 3 kinase p85 alpha;PtdIns-3-kinase regulatory subunit alpha;PtdIns-3-kinase regulatory subunit p85-alpha

Research Areas: Cancer;Metabolism;Immunology;Signal Transduction

Conjugation: Unconjugated

Host: Mouse

Species reactivity: Mouse;Rat

Application: WB;IHC-p

Isotype: IgG

Clonality: Monoclonal

Clone NO.: 3B7

UNIProt ID: P27986

Accession:

Background: Binds to activated (phosphorylated) protein-Tyr kinases, through its SH2 domain, and acts as an adapter, mediating the association of the p110 catalytic unit to the plasma membrane. Necessary for the insulin-stimulated increase in glucose uptake and glycogen synthesis in insulin-sensitive tissues.

Concentration: 1 mg/mL

Immunogen: Recombinant Protein

Buffer: PBS with 0.02% sodium azide, 0.5% protective protein and 50% glycerol, pH7.4

Purification method: Protein A purification

Dilution: WB 1:1000-2000;IHC 1:100-200

Calculated MW:

ObservedMW: 85kDa

View full details